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Inflammation is the standard im-
mune system response to any type 
of tissue injury. In the brain, acute 
inflammatory response can exacer-
bate neuronal damage, but can also 
speed up the recovery by promot-
ing tissue remodelling. This thesis 
demonstrates that p50/p105 subunit 
of nuclear factor kappa B is a criti-
cal regulator of brain inflammation, 
and thereby it also regulates neuro-
genesis. Apolipoprotein E is also an 
important regulator of post-ischemic 
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Table 1a. Old microglial markers 















High expression on 





(Chiu et al., 2013; Ito et 
al., 1998; Mori et al., 
2000; Ohsawa et al., 
2000) 
CD45 Receptor type protein 
tyrosine phosphatase, 
negative regulator of 
immune responses. 
High expression on 
peripheral leukocytes, 
lower on microglia. 
 
 
(Sedgwick et al., 1991; 
Tan et al., 2000a; Tan et 
al., 2000b) 
CD11b Subunit of integrin 
complement receptor 3, 




Expressed on all cells 
of myeloid origin, 
including monocytes, 
macrophages and 
granulocytes, also on 




Harris et al., 2000; 




in phagocytic cells. 
High expression on 





(Chiu et al., 2013; 
Holness et al., 1993; 
Kurushima et al., 2000) 
CX3CR1 Fractalkine receptor, 





subsets of natural 




(Butovsky et al., 2014; 
Cardona et al., 2006; 
Geissmann et al., 2003; 





Table 1b. New microglial-specific markers 
Gene Validated  Function Special features References 












involved in platelet 
aggregation 
High expression level on resident 
microglia but lost on amoeboid 
microglia; not expressed on 
infiltrated monocytes/ 
macrophages in EAE mouse 
model of multiple sclerosis or 
plaque-associated microglia in 
AD mouse model; total 
expression downregulated in 
spinal cord of ALS patients; also 
found on the surface of platelets. 
(Andre et al., 2003; 
Butovsky et al., 
2015; Butovsky et 
al., 2014; Crain et 
al., 2009; Elmore et 
al., 2014; Haynes et 
al., 2006; Hickman 
et al., 2013; 
Hollopeter et al., 
2001; Jay et al., 
2015; Ohsawa et al., 









and ADP to AMP 
Intermediate expression level; 
expressed on endogenous 
microglia but not infiltrated 
monocytes/macrophages in ALS 
mouse model; total expression 
downregulated in spinal cord of 
ALS patients; also expressed on 
a subset of regulatory T cells, as 
well as endothelial and smooth 
muscle cells of the vasculature. 
(Braun et al., 2000; 
Butovsky et al., 
2015; Butovsky et 
al., 2014; Butovsky 
et al., 2012; Deaglio 
et al., 2007; 
Hickman et al., 
2013) 









High expression level; secreted 
molecule; expressed on 
endogenous microglia but not 
infiltrated monocytes/ 
macrophages in ALS mouse 
model; total expression 
upregulated in spinal cord of ALS 
mice and demyelinated brain 
areas after chronic cuprizone 
treatment. 
(Bedard et al., 
2007; Butovsky et 
al., 2015; Butovsky 
et al., 2014; Chiu et 
al., 2013; Elmore et 
al., 2014; Hickman 
et al., 2013) 







High expression level; total 
expression slightly upregulated 
in demyelinated brain areas after 
chronic cuprizone treatment and 
spinal cord of ALS mouse model; 
also expressed on plasmacytoid 
dendritic cells. 
(Bedard et al., 
2007; Butovsky et 
al., 2014; Chiu et 
al., 2013; Elmore et 
al., 2014; Hickman 
et al., 2013; 







Fc receptor-like S, 
scavenger receptor 
High expression level; expressed 
on endogenous microglia but not 
infiltrated monocytes/ 
macrophages in EAE mouse 
model; microglial expression 
does not significantly change 
with the progression of ALS-like 
pathology; useful for cell sorting 
experiments. 
(Butovsky et al., 
2015; Butovsky et 
al., 2014; Elmore et 
al., 2014; Hickman 
et al., 2013) 
EAE, experimental autoimmune encephalomyelitis; AD, Alzheimer’s disease; ALS, 
amyotrophic lateral sclerosis; AMP, adenosine 5'-monophosphate. 
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Figure 1. Examples of microglial morphological phenotypes. Adapted from (Soltys et al., 





Figure 2. Microglial activation in brain injury. Brain injury, such as ischemic stroke, can 
induce a range of microglial activation patterns. Microglial activation can be skewed to M1-type-
like by for example LPS administration while CD45 upregulation promotes M2-type activation. 
M1-type-skewed microglia produce a variety of inflammatory cytokines and other pro-
inflammatory molecules that can exacerbate neuronal damage. In contrast, M2-type-skewed 
microglia may promote tissue regeneration by phagocytosing tissue debris and producing 
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Figure 3. Pathogenesis of cerebral ischemia. Events in red and green boxes are the focus of the 
present study. ATP, adenosine triphosphate; MAPK, mitogen-activated protein kinases; EAA, 
excitatory amino acids; ROS, reactive oxygen species; RNS, reactive nitrogen species; BBB, 
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Table 2. Glial-secreted factors that can affect neurogenesis 
Factor Conc. Effect RReference 
IL-1β 1 ng/ml Enhances in vitro (Shigemoto-Mogami et al., 
2014) 
IL-1β 50 ng/mg hippocampal 
tissue / 20-100 ng per rat 
Inhibits in vivo (Bachstetter et al., 2011; 
Koo and Duman, 2008) 
IFN-γ 1 ng/ml Enhances in vitro (Shigemoto-Mogami et al., 
2014) 
TNF-α 4-10 ng/ml Increases proliferation of NSCs, 
no effect on differentiation in 
vitro 
(Shigemoto-Mogami et al., 
2014; Widera et al., 2006) 
TNF-α 20 ng/ml Inhibits in vitro (Monje et al., 2003) 
IL-6 1-10 ng/ml No effect in vitro (Shigemoto-Mogami et al., 
2014) 
IL-6 50 ng/ml Inhibits in vitro (Monje et al., 2003) 
IL-6 Overexpressed Inhibits in vivo (Vallieres et al., 2002) 
IGF-1 76.5 – 7650 ng/ml Promotes neuronal 
differentiation in vitro 
(Arsenijevic and Weiss, 
1998) 
IGF-1 n.d. Enhances in vivo (Kim et al., 2015c; Trejo et 
al., 2001) 
BDNF 25 -100 ng/ml Promotes neuronal 
differentiation in vitro 
(Arsenijevic and Weiss, 
1998) 
BDNF 26-270 pg/mg hippocampal 
tissue 
Promotes differentiation and 
survival of newborn neurons 
(Lee et al., 2002a; 
Waterhouse et al., 2012) 
TGF-β 1 -100 ng/ml Dose-dependently decreases 
proliferation in vitro 
(Battista et al., 2006; 
Wachs et al., 2006) 
TGF-β 0.25 ng/h over 7 days Decreases proliferation in vivo (Wachs et al., 2006) 
TGF-β n.d. Promotes survival, migration 
and dendritic arborization of 
newborn neurons 
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Table 3. The most commonly used trangenic rodent models of Alzheimer’s disease 
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Figure 4. The summary of Nfkb1 gene translation and signaling in the brain. According to 
current understanding, full-length p105 and truncated form p50 can be co-translated from the 
same Nfkb1 mRNA. Full-length p105 then binds to p50 and keeps it inactive in the cytoplasm. 
Appropriate stimulation leads to the degradation of p105 and the release of p50 homodimers. 
P50 homodimers typically associate with histone deacetylase and function as transcriptional 
receptors. However, in a complex with other Rel proteins, such as p65 and cRel, p50 can also 
act as the transcriptional activator. P105 also affects MAP kinase signaling by stabilizing Tpl2. 
Thus, the net effect of a Nfkb1 deficiency strongly depends on context (activation of other 
signaling cascades and the presence of other transcriptional regulators). The figure is modified 
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Table 4. The summary of animals used in the present thesis. 
Study Experiment Strain Age (months) Sex 
Ia LPS injection Nfkb1-/- (C57BL/6J) 3-7 Male 
Ib Alzheimer’s disease Nfkb1 x APdE9 12 Male 
Ic* Bone marrow transplantation/ 
LPS injection 
Nfkb1-/- (B6129PF2/J)  6/10 Male 
II Forebrain ischemia (BCCAo) Nfkb1-/- (C57BL/6J) 10-14 Male and 
female 
III Permanent MCAo Nfkb1 x APdE9 18-19 Male 
IV Permanent MCAo APOE3, APOE4, C57BL/6J 16 and 4 Male 
*Unpublished data 
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Table 5. The summary of antibodies for immunohistochemistry used in the present thesis 





Wako Chemicals 1:250 Rabbit I-IV 
CD45 Pan-leukocyte marker AbD Serotec 1:100 Rat I-III 
CD68 Phagocytes AbD Serotec 1:2000 Rat I 
Ly6B.2 Neutrophils, also 
inflammatory monocytes 
AbD Serotec 1:5000 Rat I & III 
GFAP Astrocytes Dako 1:500 Rabbit II & IV 
NeuN Neuronal nuclei Merck Millipore 1:200 Mouse II 




1:200 Rabbit Ia, II, 
IV 
BrdU Proliferating cells Boehringer 
Mannheim 
Roche 
1:50 Mouse Ia 
CCL5 Activated vascular 
endothelial cells, 
inflammatory cells 
R&D Systems 1:9 Goat Ia 
Pan-Aβ Amyloid deposits, specific to 









1:500 Rabbit IV 
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Table 6. The summary of genes, the expression of which was investigated in the present thesis by 
qRT-PCR 
Gene Full name Gene function Study 
Aif1 Allograft inflammatory factor 1 / ionized 




Il1b Interleukin 1 beta (IL-1β) Cytokine, inflammatory response I-II 
Il6 Interleukin 6 (IL-6) Cytokine, inflammatory response I 
Tnf Tumor necrosis factor (TNF) Cytokine, inflammatory response I 
Ccl2 Chemokine (C-C motif) ligand 2 / monocyte 
chemoattractant protein (MCP)-1  
Chemokine, inflammatory response I 
Il10 Interleukin 10 (IL-10) Cytokine, anti-inflammatory I 
Tgfb1 Transforming growth factor beta (TGFβ) 1 Cytokine, anti-inflammatory I 
Nos2 Nitric oxide synthase 2, inducible (iNOS) Oxidoreductase, inflammatory 
response 
I-II 
Itgam Integrin alpha M / CD11b Cell adhesion molecule I 
Ccr2 Chemokine (C-C motif) receptor 2 Chemokine receptor I 
Igf1 Insulin-like growth factor 1 (IGF1) Growth factor II 
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Table 7. The summary of antibodies for flow cytochemical analysis used in the present thesis 
Antibody Target Manufacturer Experiment 
R-PE-CD11b Monocytes, granulocytes BD Biosciences or 
eBioscience 
Engraftment analysis, peripheral 
inflammation 
FITC-Ly6C Monocytes, granulocytes BD Biosciences Peripheral inflammation 
PerCP-Cy5.5-Ly6C Monocytes, granulocytes BD Biosciences Peripheral inflammation 
R-PE-Ly6G Granulocytes BD Biosciences Engraftment analysis 
PerCP-Cy5.5-Ly6G Granulocytes BD Biosciences Peripheral inflammation 
PerCP-CD45/B220 B-lymphocytes BD Biosciences Engraftment analysis 
PerCP-CD3ε T-lymphocytes BD Biosciences Engraftment analysis 
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Figure 5. TNF and MCP-1 protein level in hippocampal homogenates from intrahippocampally 
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Figure 6. Gene expression level of TNF, MCP-1 and Iba1 in the hippocampus at 5h post-
injection as measured by qRT-PCR.  Data in the graphs are shown as mean ± SEM; * p < 0.05.a
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Figure 7.:Nfkb1 gene deficiency decreases hippocampal neurogenesis in LPS-injected mice.  
Upper panel, representative pictures of DCX immunostaining in the dentate gyrus of LPS-
injected hippocampus (A, B) and the contralateral saline-injected hippocampus (C, D) of Nfkb1-
wt (A, C) and Nfkb1-ko mice (B, D), scale bar equals 200 μm. Lower panel, quantification data 
of DCX immunoreactivity in the dentate gyrus (E), and N-Myc gene expression in the 
hippocampus at 5h (F) and 5 days post-injection (G). Data in the graphs are shown as mean ± 
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Figure 8. Nfkb1 gene deficiency decreases leukocyte recruitment to the brain following 
intrahippocampal LPS injection as assessed at seven days post-injection in bone marrow 
chimeric mice.  (A) a representative picture of eGFP fluorescence in the whole hippocampal 
area of wt->wt mice, scale bar equals 500 μm. (B-D) quantification data of eGFP 
fluorescence (B), Iba1 immunoreactivity (C) and CD68 immunoreactivity (D) in the whole 
hippocampal area from 4-6 consecutive sections. Data in the graphs are shown as mean ± 
SEM; * p < 0.05, ** p < 0.01, *** p < 0.001. (F-K) the most of eGFP-positive cells in the 
dentate gyrus of the hippocampus of wt -> wt miceadid not express/expressed low levels of 
Iba1 (F-H, circles), but expressed high levels of CD68 (I-K, circles). Scale bar = 50 μm.  
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Figure 9. Nfkb1 gene deficiency and the combination of APOE4 genotype with the Western-type 
high-fat diet increase inflammatory responses in vivo. Physical injury, LPS, Aβ and ischemia can 
both activate microglia and cause alterations or large-scale damage to the BBB. In the absence 
of inhibitory p50/p50 homodimers, the activated microglia produce increased amounts of TNF 
possibly via JNK/AP-1 pathway. The dysregulation of NF-κB signaling in the Nfkb1-ko mice can 
also increase TNF production in the periphery, while the combination of APOE4 genotype with 
the high-fat diet increases post-ischemic plasma levels of IL-6. Increased TNF production 
further augments BBB damage-induced leukocyte infiltration thereby increasing the production 
of ROS and inflammatory cytokines in the brain parenchyma.  Elevated ROS production in the 
Nfkb1-ko brain and possibly reduced IgG infiltration due to lower plasma IgG levels prevent 
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Inflammation is the standard im-
mune system response to any type 
of tissue injury. In the brain, acute 
inflammatory response can exacer-
bate neuronal damage, but can also 
speed up the recovery by promot-
ing tissue remodelling. This thesis 
demonstrates that p50/p105 subunit 
of nuclear factor kappa B is a criti-
cal regulator of brain inflammation, 
and thereby it also regulates neuro-
genesis. Apolipoprotein E is also an 
important regulator of post-ischemic 
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